Stichting Aescap Life Sciences 13D and 13G filings for ProQR Therapeutics N.V.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-09 5:00 pm Purchase |
2022-12-31 | 13G | ProQR Therapeutics N.V. PRQR |
Stichting Aescap Life Sciences | 5,406,159 7.600% |
578,787 (+11.99%) |
Filing |
| 2022-02-04 4:58 pm Purchase |
2021-12-31 | 13G | ProQR Therapeutics N.V. PRQR |
Stichting Aescap Life Sciences | 4,827,372 6.800% |
1,623,176 (+50.66%) |
Filing |
| 2021-02-09 5:00 pm Purchase |
2020-12-31 | 13G | ProQR Therapeutics N.V. PRQR |
Stichting Aescap Life Sciences | 3,204,196 6.400% |
3,204,196 (New Position) |
Filing |